Theoretically, damage of organs containing CK activity should release soluble enzyme into the general circulation. Gastrointestinal (GI) tissue has been reported to contain total CK activity only less than skeletal and cardiac muscles, and comparable to CK activity of brain per gram wet tissue with almost exclusively BB isoenzyme.6 It has been well documented that acute brain damage will effect the release of CK-BB into the blood circulation. However, there are few reports on CK isoenzyme in patients with damage of the GI tract. The present study was initiated to detect the frequency of occurrence of CK-BB and CK-MB isoenzymes in the sera of patients after GI surgery.
in 23°,. MB content varied from 0O8 to 10 .3% of the total creatine kinase activity, and the BB content from 0-6 to 18-4%. The CK-BB was probably of gastrointestinal origin, since gastrointestinal tract contains high CK activity with BB isoenzyme predominating. A cardiac origin for the observed serum CK-MB isoenzyme increase would seem the most likely, although no patients showed evidence of electrocardiographic changes. Increased CK-MB activity has been observed in myocardial ischaemia without infarction.
Recent reports by workers using a variety of sensitive methods have indicated that the presence of the BB isoenzyme of creatine kinase (EC 2.4.2.7.) in human serum is not as rare as was originally supposed. CK-BB activity has been reported in sera of patients with severe acute brain injury,1 2 chronic renal failure, haemodialysis, renal transplant,34 and prostate resection.5 Although the findings appear to have little diagnostic significance in their own right, they are important in relation to certain isoenzyme separation techniques that are now in use. Theoretically, damage of organs containing CK activity should release soluble enzyme into the general circulation. Gastrointestinal (GI) tissue has been reported to contain total CK activity only less than skeletal and cardiac muscles, and comparable to CK activity of brain per gram wet tissue with almost exclusively BB isoenzyme.6 It has been well documented that acute brain damage will effect the release of CK-BB into the blood circulation. However, there are few reports on CK isoenzyme in patients with damage of the GI tract. The present study was initiated to detect the frequency of occurrence of CK-BB and CK-MB isoenzymes in the sera of patients after GI surgery. Repeat CK and isoenzyme studies were done on 22 patients 20-24 h after the operation. Only two patients had normal total CK activity. The total CK activity was slightly greater in the samples taken 20-24 h (mean 316; range 52-1451 U/I) than in the samples taken two to four hours after surgery. Blood from two of these patients showed MB activity of 11 U/I and 3-5 U/I or 0-8 and 1-5 % of total activity, while only one patient had BB activity of 3-5 U/I (0 6%). These three patients did not show CK-MB or CK-BB in the samples taken at two to four hours after surgery. CK-MB or CK-BB isoenzymes were more frequently demonstrated in samples taken two to four hours after surgery than in the samples taken 20-24 h after surgery. The Table 3 summarises the results of our CK enzyme 
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Discussion
Henry et al1 reported that surgery involving the GI tract does not increase serum MB values, nor is BB generally detected after such a procedure.
In the present study, however, CK-MB was found in 33% and CK-BB detected in 23% of patients.
The CK-BB found in nine of 30 patients was probably of gastric or intestinal origin, since this isoenzyme study showed that CK-BB is the major isoenzyme in GI tissue. It is unlikely that the effects of anaesthesia on the brain could have resulted in transient release of the CK-BB into the circulation since no CK-BB increase was seen in controls after orthopaedic operations. Two reasons speak against the theory that CK-MB observed in nine patients is of GI origin. Firstly, enzyme assays on tissue and serum were simultaneously performed on 10 patients; two patients (patients 4 and lOin Table2) had CK-MB of 3-6 U/I and 11 U/I respectively, with serum CK-BB undetectable. These two patients had tissue CK-BB of 99 and 970% respectively, while tissue CK-MB ranged from I to 3%. If the CK-MB was of GI origin due to surgical trauma, CK-BB should also be present with much higher activity unless the release mechanism of both CK-MB and CK-BB isoenzyme is different. Secondly, CK-MB was more frequently detected than CK-BB as shown in Table  2 . This also contradicts the theory that CK-MB is of GI origin, because the GI tract contained considerably less CK-MB than CK-BB. ItanolI demonstrated raised BB activity in a patient with membranous colitis. Doran'2 reported the presence of CK-MB and CK-BB in a patient suffering from infarction of the colon. Although the source of CK-BB was attributed to intestinal necrosis, the source of CK-MB was not explained. In this study, two similar cases were encountered showing extensive necrosis of the small and large This study demonstrated that CK-MB or CK-BB, or both, can be measurable in some patients after GI surgery, with infarcted intestine and with progressive malignant disease. The CK-BB was probably of GI origin, or was produced by malignant neoplastic cells. Transient release from brain due to anaesthetic effect should also be considered, but would seem unlikely because none of the patients in the control group had measurable CK-BB. A cardiac origin for the observed serum CK-MB isoenzyme increase would seem the most likely, although no patients studied showed evidence of electrocardiographic changes. Increased CK-MB activity has been observed in myocardial ischaemia without infarction. Incubation of CK-BB in human plasma has been shown to convert most of the enzyme into a form in which electrophoretic mobility corresponds to the MB isoenzyme, and it has been suggested that similar change can occur in the circulation.'4 Therefore, this mechanism might account for the observed CK-MB in this study.
The presence of significant amounts of BB isoenzyme, whatever its tissue origin, will falsify MB assays which use methods unable to separate CK-MB from CK-BB.15 16 The laboratories using column chromatography to identify CK-MB should be aware that in the presence of CK-BB, the ionic strength of the MB eluting buffer is critical. Eckfeldt and Kershawl6 demonstrated that using the Harleco Ultrazyme kit with 0 25 mol/l sodium chloride buffers, very significant amounts of CK-BB were eluted in the CK-MB fraction. Our routine clinical chemistry laboratory using kits from Roche Diagnostics Division experienced a similar phenomenon because their CK-MB buffer also contains 0 25 mol/l sodium chloride.
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